Fixed 30 mCi 131I-iodine therapy without recombinant human thyroid-stimulating hormone stimulation as an attractive therapeutic alternative in nontoxic nodular …
CM Riguetto, VP Miguel, EJ Pavin… - Nuclear Medicine …, 2020 - journals.lww.com
Objective To analyze outcomes of patients with compressive nontoxic multinodular goiter
after 131I-iodine 30 mCi treatment without previous use of recombinant human thyroid-
stimulating hormone or methimazole. Methods We evaluated fixed-dose radioiodine therapy
outcomes in patients with nontoxic multinodular goiter who did not accept thyroidectomy as
a therapeutic option. Laboratory thyroid function and thyroid volume estimated by ultrasound
were assessed before and one year after radioiodine therapy. Results Twenty euthyroid …
after 131I-iodine 30 mCi treatment without previous use of recombinant human thyroid-
stimulating hormone or methimazole. Methods We evaluated fixed-dose radioiodine therapy
outcomes in patients with nontoxic multinodular goiter who did not accept thyroidectomy as
a therapeutic option. Laboratory thyroid function and thyroid volume estimated by ultrasound
were assessed before and one year after radioiodine therapy. Results Twenty euthyroid …
以上显示的是最相近的搜索结果。 查看全部搜索结果